AAMU
CCXI

Amundi Asset Management US’s ChemoCentryx, Inc. CCXI Stock Holding History

Amundi Asset Management US’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$302K Hold
5,900
– – ﹤0.01% 1415
2020
Q4 		$365K Hold
5,900
– – ﹤0.01% 1348
2020
Q3 		$323K Hold
5,900
– – ﹤0.01% 1312
2020
Q2 		$339K Hold
5,900
– – ﹤0.01% 1305
2020
Q1 		$237K Buy
+5,900
New +$251K ﹤0.01% 1302

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Amundi Asset Management US's CCXI Position: Q1 2021 in Review

Amundi Asset Management US held its ChemoCentryx, Inc. (CCXI) position steady in Q1 2021 at 5,900 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

Amundi Asset Management US first reported a position in CCXI in Q1 2020 and has held it in 5 quarters since. The position peaked at $365K in Q4 2020. 183 funds tracked by Wall St. Rank hold CCXI as of Q1 2021.

  • Amundi Asset Management US held 5,900 shares of ChemoCentryx, Inc. worth $302K as of Q1 2021.
  • Amundi Asset Management US left its ChemoCentryx, Inc. share count unchanged in Q1 2021.
  • ChemoCentryx, Inc. made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1415 holding.
  • Amundi Asset Management US first reported a position in ChemoCentryx, Inc. in Q1 2020 and has held it in 5 quarters since.
  • Amundi Asset Management US's ChemoCentryx, Inc. position peaked at $365K in Q4 2020.
  • 183 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.